Study of Tysabri (Natalizumab) in Patients Who Failed Anti-TNF-α Therapy
This study has been withdrawn prior to enrollment.
(Study sponsor decided to withdraw the current study prior to enrollment of first participant.)
Sponsor:
Elan Pharmaceuticals
Collaborator:
Biogen Idec
Information provided by:
Elan Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00801125
First received: December 1, 2008
Last updated: January 23, 2009
Last verified: January 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Study Status: | This study has been withdrawn prior to enrollment. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |